Data / Drug companies / Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.: 65 products in the FDA NDC directory, labeler code 0555
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Teva Pharmaceuticals USA, Inc. (labeler code 0555) lists 65 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 62 prescription drugs, 3 drugs for further processing. Its main marketing category is generic drugs (ANDA). The newest product started marketing on May 24, 2023.
The request: Watch Teva Pharmaceuticals USA, Inc. (FDA labeler code 0555): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0555
- Products in commercial distribution
- 65
- Packages
- 83
- Finished drugs by generic name
- 25
- Prescription products
- 62
- Over the counter products
- 0
- Controlled substance products
- Schedule II 9, Schedule IV 3
- Flagged as original packager
- 61 of 61 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 3
- Earliest marketing start
- September 1, 1972
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 61 | 93.8% |
| Drugs for further processing | 3 | 4.6% |
| Authorized generics (NDA) | 1 | 1.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 62 | 95.4% |
| Drugs for further processing | 3 | 4.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Norethindrone and ethinyl estradiol | 6 | 12 |
| Isotretinoin | 4 | 16 |
| Medroxyprogesterone acetate | 3 | 23 |
| Levonorgestrel and ethinyl estradiol | 3 | 19 |
| Norethindrone acetate and ethinyl estradiol | 3 | 10 |
| Estradiol | 3 | 53 |
| Chlordiazepoxide hydrochloride | 3 | 13 |
| Hydroxyzine pamoate | 3 | 30 |
| Danazol | 3 | 4 |
| Isoniazid | 2 | 15 |
| Megestrol acetate | 2 | 17 |
| Norgestimate and ethinyl estradiol | 2 | 20 |
| Dextroamphetamine sulfate | 2 | 17 |
| Desogestrel and ethinyl estradiol | 2 | 12 |
| Leucovorin calcium | 2 | 18 |
| Trazodone hydrochloride | 1 | 39 |
| Norgestrel and ethinyl estradiol | 1 | 7 |
| Desogestrel/ethinyl estradiol and ethinyl estradiol | 1 | 4 |
| Hydroxyurea | 1 | 14 |
| Ethynodiol diacetate and ethinyl estradiol | 1 | 4 |
| Norethindrone acetate | 1 | 6 |
| Amiloride hydrochloride and hydrochlorothiazide | 1 | 1 |
| Levonorgestrel / ethinyl estradiol | 1 | 1 |
| Mefloquine hydrochloride | 1 | 3 |
| Methotrexate | 1 | 31 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 32 | 49.2% |
| Kit | 19 | 29.2% |
| Capsule | 10 | 15.4% |
| Capsule, liquid filled | 4 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Amiloride hydrochloride and hydrochlorothiazide | 0555-0483 | Tablet | Drugs for further processing | May 24, 2023 |
| Trazodone Hydrochloride | 0555-0711 | Tablet | Generic drugs (ANDA) | December 9, 2021 |
| Leucovorin calcium | 0555-0485 | Tablet | Drugs for further processing | June 10, 2021 |
| Leucovorin calcium | 0555-0484 | Tablet | Drugs for further processing | June 10, 2021 |
| Tri-Legest Fe 28 Day | 0555-9032 | Kit | Generic drugs (ANDA) | October 26, 2007 |
| Balziva | 0555-9034 | Kit | Generic drugs (ANDA) | October 16, 2006 |
| Claravis | 0555-1056 | Capsule, liquid filled | Generic drugs (ANDA) | May 18, 2006 |
| Kelnor 1/35 | 0555-9064 | Kit | Generic drugs (ANDA) | June 20, 2005 |
| Aranelle | 0555-9066 | Kit | Generic drugs (ANDA) | October 4, 2004 |
| Velivet Triphasic Regimen | 0555-9051 | Kit | Generic drugs (ANDA) | March 1, 2004 |
| Mefloquine Hydrochloride | 0555-0171 | Tablet | Generic drugs (ANDA) | January 6, 2004 |
| Tri-Sprintec | 0555-9018 | Kit | Generic drugs (ANDA) | December 29, 2003 |
| Jolessa | 0555-9123 | Kit | Authorized generics (NDA) | October 13, 2003 |
| Junel Fe 28 Day | 0555-9028 | Kit | Generic drugs (ANDA) | September 18, 2003 |
| Junel 21 Day | 0555-9027 | Tablet | Generic drugs (ANDA) | September 18, 2003 |
| Junel Fe 28 Day | 0555-9026 | Kit | Generic drugs (ANDA) | September 18, 2003 |
| Junel 21 Day | 0555-9025 | Tablet | Generic drugs (ANDA) | September 18, 2003 |
| Claravis | 0555-1057 | Capsule, liquid filled | Generic drugs (ANDA) | May 9, 2003 |
| Claravis | 0555-1055 | Capsule, liquid filled | Generic drugs (ANDA) | May 9, 2003 |
| Claravis | 0555-1054 | Capsule, liquid filled | Generic drugs (ANDA) | May 9, 2003 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0555-0777 | Tablet | Generic drugs (ANDA) | March 19, 2003 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0555-0776 | Tablet | Generic drugs (ANDA) | March 19, 2003 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | 0555-0775 | Tablet | Generic drugs (ANDA) | March 19, 2003 |
| Nortrel 7/7/7 (28 Day Regimen) | 0555-9012 | Kit | Generic drugs (ANDA) | January 2, 2003 |
| Sprintec | 0555-9016 | Kit | Generic drugs (ANDA) | September 26, 2002 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.